Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
COVID-19 is a new disease caused by the Sars-CoV-2 virus and the vast majority of patients have symptoms similar to a flu-like syndrome. A small portion of those infected ends up being hospitalized and may develop with the most severe presentation of the disease. Data from Chinese series report tha...
Main Authors: | Andre Feldman, Guilherme D’Andréa Saba Arruda, Olga Ferreira de Souza |
---|---|
Format: | Article |
Language: | English |
Published: |
Linceu Editorial
2020-11-01
|
Series: | Journal of Cardiac Arrhythmias |
Online Access: | https://jca.emnuvens.com.br/jca/article/view/3405 |
Similar Items
-
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
by: Andre Feldman, et al.
Published: (2020-11-01) -
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
by: Andre Feldman, et al.
Published: (2020-11-01) -
Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
by: José Silva-Cardoso, et al.
Published: (2022-10-01) -
The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020-08-01) -
Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
by: Filipe Ferrari, et al.
Published: (2021-04-01)